Samsung Bioepis and Biogen receive approval in Canada for AMD, choroidal neovascularization, diabetic macular edema and retinal vein occlusion

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    R & D Focus Drug News. March 11, 2022